Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
Nucleic acid therapies such as gene editing hold promise for treating cancer, but delivery into cells is challenging due to membrane impermeability and instability of nucleic acids. At CD Formulation, silica nanoparticles (SiNPs) have been developed to deliver nucleic acids like siRNA, miRNA, shRNA and CRISPR/Cas9 for cancer treatment.
SiNPs offer several advantages for delivering nucleic acids. Their ease of synthesis, surface modification, and high loading capacity make them suitable for efficient encapsulation and protection of nucleic acids. The unique features of SiNPs, such as biocompatibility, stability, and controlled cargo release, enable targeted delivery to specific cells and tissues.
Different ways for SiNPs to deliver nucleic acids (Ramos-Valle A.; et al., 2023)
We use a variety of advanced synthetic technologies to prepare DNA, including:
Subsequent purification steps such as desalting, OPC, HPLC and PAGE are carefully executed to obtain high-purity nucleic acid drugs of excellent quality and efficacy.
Through techniques like sol-gel synthesis and templating, we condense silica precursors like tetraethyl orthosilicate in the presence of structure-directing agents to form porous nanoparticles. Careful control of parameters (water content, catalyst concentration and temperature) allows the production of silica particles with tailored properties.
Electrostatic interaction | Nucleic acids can be adsorbed onto the surface of silica nanoparticles through electrostatic interactions or hydrophobic interactions. |
Incubation | Simply incubating nucleic acids with pre-formed silica nanoparticles allows the acids to diffuse into and adsorb within the nanopores. |
Co-condensation | Nucleic acids are mixed with silica precursors during nanoparticle formation using the sol-gel process. As the particles polymerize around the nucleic acids, they become encapsulated within the silica matrix. |
SiNP Characterization |
|
Particles are subjected to high temperatures, extreme pH levels, and oxidative stressors like hydrogen peroxide for set time periods.
Our preparation of double/triple layer silica nanoparticles involves the sequential deposition of silica layers onto core particles, resulting in a multilayer structure. By controlling deposition conditions, we can achieve precise layer thickness and alignment. We can also coat the surface of SiNPs with specific polymers to achieve specific functions.
Gene Expression |
|
Gene Silencing |
|
Gene Editing |
|
At CD Formulation, we provide fully customized silica nanoparticle development services to overcome challenges in nucleic acid delivery. If you seek a reliable partner for synthesizing, loading and characterizing silica nanoparticles, please contact us to design a tailored solution for your delivery needs.
References